Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events

US Patent 10612043 · Granted Apr 7, 2020

Estimated economic value: $25,430,000

Assignee

Inventors

View full patent text on Google Patents →